Lihao Zhao
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 14, 2023
GDC-0349 inhibits non-small cell lung cancer cell growth.
Journal: Cell death & disease
Published: July 30, 2020
Mean apparent diffusion coefficient in a single slice may predict tumor response to whole-brain radiation therapy in non-small-cell lung cancer patients with brain metastases.
Journal: European radiology
Published: July 01, 2020
Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.
Journal: Radiation oncology (London, England)
Published: June 01, 2020
Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.
Journal: Frontiers in endocrinology
Published: March 12, 2020
CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-145.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 28, 2019
Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant.
Journal: Radiation oncology (London, England)
Published: October 07, 2019
Clinical Value Of Apatinib As A Salvage Treatment In Patients With Chemo-Refractory Advanced Cervical Cancer.
Journal: OncoTargets and therapy
Published: September 09, 2019
Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545.
Journal: Cell death & disease
Published: May 11, 2019
Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study.
Journal: Radiation oncology (London, England)
Published: June 16, 2018
Treatment outcome comparisons between exons 19 and 21 EGFR mutations for non-small-cell lung cancer patients with malignant pleural effusion after first-line and second-line tyrosine kinase inhibitors.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 17, 2017
Last Updated: 09/26/2026